Effectiveness of Antihypertensive Medications in Office and Ambulatory Settings: A Placebo‐Controlled Comparison of Atenolol, Metoprolol, Chlorthalidone, Verapamil, and an Atenolol‐Chlorthalidone Combination

The Journal of Clinical Pharmacology

Volumn 32, Issue 6, 1992, Pages 564-570

  Durel, Lynn A ^a   Hayashi, Peter J ^a   Weidler, Donald J ^a   Schneiderman, Neil ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CHLORTALIDONE; METOPROLOL; METOPROLOL TARTRATE; PLACEBO; VERAPAMIL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HYPERTENSION; MALE;

ADULT; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHLORTHALIDONE; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMAN; HYPERTENSION; METOPROLOL; MIDDLE AGE; MONITORING, PHYSIOLOGIC; OFFICE VISITS; SUPPORT, U.S. GOV'T, P.H.S.; VERAPAMIL;

EID: 0026659606     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/009127009203200613     Document Type: Article

References (25)

1. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress
2. The prognostic value of ambulatory blood pressure monitoring
3. Relationship of 24‐hour blood pressure mean and variability to severity of target organ damage in hypertension
4. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension
5. Average daily blood pressure, not office blood pressure, determines left ventricular function in patients with hypertension
6. Disparities in blood pressure control under various antihypertensive regimens
7. Comparison of betaxolol with verapamil in hypertensive patients: Discrepancy between office and ambulatory blood pressures
8. Racial differences in response to antihypertensive drugs: A focus on verapamil
9. Comparative study of the antihypertensive effect of verapamil and atenolol
10. Verapamil and propranolol in essential hypertension
11. Antihypertensive therapy with calcium‐channel blockers: Comparison with beta blockers
12. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long‐term therapy
13. Predicting home and work blood pressure measurements from resting baselines and laboratory reactivity in black and white Americans
14. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting
15. Crossover factorial studies with antihypertensive drugs
16. Once‐daily verapamil in the treatment of mild‐to‐moderate hypertension: A double‐blind placebo‐controlled dose‐ranging study
17. Characterization of antihypertensive therapy by whole‐day blood pressure monitoring
18. Verapamil and 24‐hour ambulatory blood pressure monitoring in essential hypertension
19. Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk
20. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension
21. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Study
22. Hypertension: Definitions, natural histories, and consequences
23. Blood pressure reductions during self‐recording of the home blood pressure
24. How common is white coat hypertension